SSTR2 - somatostatin receptor 2 Gene
Species: Macaca mulatta
Gene Type: protein coding
Gene ID: 695526
About SSTR2
Primary_assembly 16: 69,482,580-69,494,832 forward strand.Mmul_10:CM014351.1
This gene has 2 transcripts (splice variants), 264 orthologues and 16 paralogues.
SSTR2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| XM_001085574.4 | XP_001085574.3 | somatostatin receptor type 2 |
SSTR2 Protein Structure
7tmA_SSTR2
7tmA_SSTR2: cd15971 (43 - 322)
7tmA_SSTR2
7tmA_SSTR2: cd15971 (44 - 70)
7tmA_SSTR2
7tmA_SSTR2: cd15971 (77 - 103)
7tmA_SSTR2
7tmA_SSTR2: cd15971 (114 - 144)
7tmA_SSTR2
7tmA_SSTR2: cd15971 (156 - 178)
7tmA_SSTR2
7tmA_SSTR2: cd15971 (204 - 233)
7tmA_SSTR2
7tmA_SSTR2: cd15971 (248 - 278)
7tmA_SSTR2
7tmA_SSTR2: cd15971 (290 - 315)
- 0
- 100
- 200
- 300
- 369 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
somatostatin receptor type 2 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P0036 | Octreotide | Agonist | 99.96% | Unkown |
| HY-P0036B | Octreotide pamoate | Agonist | / | Unkown |
Clinical Phase
Bioactive Molecules
(4)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-P5362 | NODAGA-LM3 | Antagonist | 99.65% | Phase 2 |
| HY-P0024 | Veldoreotide | Activator | / | Phase 2 |
| HY-106103 | Seglitide | Modulator | 99.30% | Phase 2 |
| HY-P3294 | Onzigolide | Agonist | / | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(21)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P1932 | Cortistatin-14 | 99.98% | Unkown | |
| HY-P1202 | CYN 154806 | Antagonist | 99.90% | Unkown |
| HY-P10137 | Satoreotide | Antagonist | 98.80% | Unkown |
| HY-P3124A | BIM-23190 hydrochloride | Agonist | 99.33% | Unkown |
| HY-P1202A | CYN 154806 TFA | Antagonist | 98.30% | Unkown |
| HY-P0024A | Veldoreotide TFA | Agonist | 98.97% | Unkown |
| HY-P4452 | PRL 2915 | Antagonist | 99.92% | Unkown |
| HY-P2090A | Angiopeptin TFA | Agonist | 99.01% | Unkown |
| HY-P3618 | Cortistatin-29 (reduced) | 98.12% | Unkown | |
| HY-P5362A | NODAGA-LM3 TFA | Antagonist | / | Unkown |
| HY-P4469 | PRL 3195 | Antagonist | / | Unkown |
| HY-P10239 | Tyr3-Octreotate | Ligand | 99.76% | Unkown |
| HY-P2545 | [Tyr1]-Somatostatin-14 | / | Unkown | |
| HY-P2150 | Cortistatin-29 (rat) | / | Unkown | |
| HY-P0042 | BIM-23197 | Agonist | / | Unkown |
| HY-P11485 | JR11-PEG3-HBED-CC-PSMA-03 | Antagonist | / | Unkown |
| HY-110161 | sst2 Receptor agonist-1 | Agonist | / | Unkown |
| HY-P3124 | BIM-23190 | Agonist | / | Unkown |
| HY-P2090 | Angiopeptin | Agonist | / | Unkown |
| HY-P11488 | JR11-PEG3-DOTA-PSMA-03 | Ligand | / | Unkown |
| HY-P2434 | AP102 | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service